Yaqrit Limited is developing a family of liver disease treatments that will transform the lives of patients around the world. We are a spinout from University College London (UCL), and what we do is based on 20 years' of research by Professor Rajiv Jalan and his team at the Royal Free Hospital campus. UCL is one of the world's top five universities (http://www.ucl.ac.uk/news/news-articles/0914/160914-ucl-qs-rankings-5th) For further information, contact us at Troels@yaqrit.com
| Website | http://www.yaqrit.com |
| Revenue | $5 million |
| Employees | 14 (5 on RocketReach) |
| Founded | 2014 |
| Technologies | |
| Industry | Biotechnology Research, Manufacturing General, Biotechnology, Manufacturing, Science and Engineering, Life Science, Medical, Health Care, Medical Device, Pharmaceutical |
| Keywords | Liver Disease Treatment, Liver Health, Cirrhosis Treatment, Hepatitis Treatment, Nash Treatment, Liver Regeneration, Regenerative Medicine, Pharmaceutical Research, Biotechnology |
| Competitors | Gilead Sciences, AbbVie, Bristol Myers Squibb, Merck & Co., Inc., Johnson & Johnson, Roche, Amgen, Lilly India, Pfizer, Novartis +31 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Yaqrit employee's phone or email?
The Yaqrit annual revenue was $5 million in 2026.
Troels Jordansen is the CEO of Yaqrit.
5 people are employed at Yaqrit.
Yaqrit is based in London, England.
The NAICS codes for Yaqrit are [325, 3254, 32, 32541].
The SIC codes for Yaqrit are [283, 28].